oxybutynin has been researched along with Recrudescence in 12 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously reported short-term results from a perioperative randomized controlled trial comparing usual care with an intervention involving (1) brief counseling by the preadmission nurse, (2) smoking cessation brochures, (3) referral to a telephone quitline, and (4) a free 6-week supply of transdermal nicotine replacement." | 5.20 | Long-term quit rates after a perioperative smoking cessation randomized controlled trial. ( Buhrmann, O; Jones, PM; Landry, J; Lee, SM; Morley-Forster, P, 2015) |
| "The physician's role in treating enuresis is first to rule out structural causes for enuresis." | 2.39 | Diagnosis and management of nocturnal enuresis. ( Gandhi, KK, 1994) |
| "Nocturnal enuresis is a common childhood disorder." | 1.31 | Combined pharmacotherapy for nocturnal enuresis. ( Fujinaga, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Yamashiro, Y, 2001) |
| "Chronic bacterial prostatitis was diagnosed in 15 patients (20." | 1.29 | Ten years experience with chronic prostatitis in Africans. ( Magoha, GA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, L | 1 |
| Keys, C | 1 |
| Lam, JP | 1 |
| Koff, SA | 1 |
| Murtagh, DS | 1 |
| Gandhi, KK | 1 |
| Magoha, GA | 1 |
| Kaneko, K | 1 |
| Fujinaga, S | 1 |
| Ohtomo, Y | 1 |
| Shimizu, T | 1 |
| Yamashiro, Y | 1 |
| Lee, SM | 1 |
| Landry, J | 1 |
| Jones, PM | 1 |
| Buhrmann, O | 1 |
| Morley-Forster, P | 1 |
| Schmidt, PJ | 1 |
| Ben Dor, R | 1 |
| Martinez, PE | 1 |
| Guerrieri, GM | 1 |
| Harsh, VL | 1 |
| Thompson, K | 1 |
| Koziol, DE | 1 |
| Nieman, LK | 1 |
| Rubinow, DR | 1 |
| Ciancio, G | 1 |
| Colina, M | 1 |
| La Corte, R | 1 |
| Lo Monaco, A | 1 |
| De Leonardis, F | 1 |
| Trotta, F | 1 |
| Govoni, M | 1 |
| Lycett, D | 1 |
| Munafò, M | 1 |
| Johnstone, E | 1 |
| Murphy, M | 1 |
| Aveyard, P | 1 |
| Berlin, I | 1 |
| Jacob, N | 1 |
| Coudert, M | 1 |
| Perriot, J | 1 |
| Schultz, L | 1 |
| Rodon, N | 1 |
| Javitz, HS | 1 |
| Swan, GE | 1 |
| Lerman, C | 1 |
| Cummins, S | 1 |
| Zhu, SH | 1 |
| Gamst, A | 1 |
| Kirby, C | 1 |
| Brandstein, K | 1 |
| Klonoff-Cohen, H | 1 |
| Chaplin, E | 1 |
| Morris, T | 1 |
| Seymann, G | 1 |
| Lee, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison Study of a Low-Fat Diet Supplemented With Fish Oil and a Standard Western Diet in Individuals With Prostate Cancer[NCT00798876] | 56 participants (Actual) | Interventional | 2001-12-18 | Completed | |||
| The Effect of a Perioperative Smoking Cessation Program on Rates of Smoking Cessation/Reduction and Perioperative Complications: a Randomized Clinical Trial.[NCT01260233] | 168 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis[NCT05282277] | Phase 4 | 103 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | ||
| The Effects of Acute Withdrawal of Estradiol on Mood Symptoms in Women With Perimenopausal Depression[NCT00060736] | 60 participants (Actual) | Observational | 2003-05-05 | Completed | |||
| Effects of a Tissue Selective Estrogen Complex (TESC) on Depression and the Neural Reward System in the Perimenopause[NCT03740009] | Phase 4 | 20 participants (Actual) | Interventional | 2019-01-02 | Completed | ||
| Does Dose Adjustment of Nicotine Replacement Therapies According to Saliva Cotinine Increase Efficacy of These Treatments of Assistance To the Nicotinic Weaning Of the High-Risk Patients?[NCT00235313] | Phase 4 | 300 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
| Smoking Cessation in Hospitalized Smokers[NCT01289275] | Phase 4 | 1,270 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The primary outcome measure is functional magnetic resonance imaging (fMRI) data collected during a Monetary Incentive Delay (MID) Task. All participants will complete the fMRI Monetary Incentive Delay (MID) task at baseline and at 3 weeks. During the task, participants need to select the correct response during win and lose conditions by pressing a button on a button box in the MRI. Participant's blood-oxygen-level dependent (BOLD) activation response (A measurement of oxygen level that is released to neurons since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen to perform the tasks.) is measured while they performed the task in MRI scanner." (NCT03740009)
Timeframe: Baseline to 3 weeks
| Intervention | percent signal change (Mean) | |||||
|---|---|---|---|---|---|---|
| Caudate Baseline | Caudate Posttreatment | Nucleus Accumbens Baseline | Nucleus Accumbens Posttreatment | Putamen Baseline | Putamen Posttreatment | |
| Perimenopausal Women, Depressed | .0704 | .0475 | .0623 | .0280 | .0399 | .0408 |
The second primary outcome measure uses the Mood and Anxiety Symptoms Questionnaire - Anhedonic Depression Scale (MASQ-AD) to examine symptom change. All participants will complete the MASQ-AD at each study visit, which measures their current symptoms of depression and anxiety. Scores range from 22 to 110 with lower scores reflecting a better outcome. (NCT03740009)
Timeframe: Baseline, week 2, week 3, week 4 (post treatment)
| Intervention | score on a scale (Mean) | |||
|---|---|---|---|---|
| Baseline Week 1 | Week 2 | Week 3 | Post Treatment Week 4 | |
| Perimenopausal Women, Depressed | 72.1 | 62.4 | 57.2 | 54.5 |
All participants will receive an assessment Interview 2-months after their initial contact with the Helpline. The interview will cover, as appropriate, tobacco use, use of quitting aids, pattern of quitting (including slips and relapse situations), and satisfaction with the services. The interview will be conducted over the telephone. (NCT01289275)
Timeframe: 2-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 19.6 |
| Nicotine Patches | 22.5 |
| Telephone Counseling + Patches | 24.0 |
| Brief Hospital Counseling | 18.4 |
All participants will receive an assessment Interview 6-months after their initial contact with the Helpline. The interview will cover, as appropriate, tobacco use, use of quitting aids, pattern of quitting (including slips and relapse situations), and satisfaction with the services. The interview will be conducted over the telephone. Intention to treat analysis. (NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 18.0 |
| Nicotine Patches | 23.4 |
| Telephone Counseling and Nicotine Patches | 22.1 |
| Brief Hospital Counseling | 18.7 |
(NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 70.0 |
| Nicotine Patches | 78.9 |
| Telephone Counseling + Patches | 77.6 |
| Brief Hospital Counseling | 69.7 |
(NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Telephone Counseling | 45 |
| Nicotine Patches | 50 |
| Telephone Counseling + Patches | 53 |
| Brief Hospital Counseling | 51 |
1 review available for oxybutynin and Recrudescence
| Article | Year |
|---|---|
Diagnosis and management of nocturnal enuresis.
Topics: Age Factors; Behavior Therapy; Child; Circadian Rhythm; Clinical Protocols; Deamino Arginine Vasopre | 1994 |
6 trials available for oxybutynin and Recrudescence
| Article | Year |
|---|---|
Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Health Behavior; Health Knowledge, Attitudes, | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Topics: Aged; Cross-Over Studies; Depression; Depressive Disorder; Double-Blind Method; Estradiol; Estrogen | 2015 |
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series.
Topics: Adult; Behcet Syndrome; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; R | 2010 |
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
Topics: Administration, Buccal; Cardiovascular Diseases; Comorbidity; Cotinine; Counseling; Diabetes Mellitu | 2011 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Fe | 2011 |
Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.
Topics: Administration, Cutaneous; Aftercare; California; Cost-Benefit Analysis; Counseling; Drug Costs; Hos | 2012 |
5 other studies available for oxybutynin and Recrudescence
| Article | Year |
|---|---|
Bladder calculus formation on the tip of a migrated disused ventriculoperitoneal shunt.
Topics: Abnormalities, Multiple; Child; Cholinergic Antagonists; Combined Modality Therapy; Cystoscopy; Equi | 2013 |
The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution.
Topics: Adolescent; Anti-Infective Agents, Urinary; Child; Child, Preschool; Drug Combinations; Female; Huma | 1983 |
Ten years experience with chronic prostatitis in Africans.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Humans; Keny | 1996 |
Combined pharmacotherapy for nocturnal enuresis.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzilates; Child; Cholinergic Antagonists; Drug Th | 2001 |
Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers.
Topics: Adult; Aged; Body Mass Index; England; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; | 2011 |